Currently, implantable cardioverter‐defibrillators (ICDs) are considered for the heart failure patient with both ischemic and nonischemic heart disease, New York Heart Association (NYHA) class II or III symptoms, and an ejection fraction (EF) ≤35%. Cardiac resynchronization therapy (CRT) should ...
vasodilatoragents, and positiveinotropes. Certain subgroups may benefit fromBi-ventricular pacemakerplacement or surgical remodelling of the heart. While these treatment modalities may make the patient symptomatically
Automated collection and analysis patient care system and method for diagnosing and monitoring congestive heart failure and outcomes thereof An automated system and method for diagnosing and monitoring congestive heart failure and outcomes thereof is described. A plurality of monitoring sets is retrieved ...
A patient who developed erythrocytosis during the course of congestive heart failure due to acute myocarditis 来自 ResearchGate 喜欢 0 阅读量: 27 作者:K Kato,M Yamamoto,T Kato,T Mitsui,Y Asano 摘要: Understanding the mechanisms of reactive sputtering is thought to be crucial to obtain a better...
Treatment for a patient with congestive heart failureImproved devices for these procedures include a minimally invasive grasping device having an inner lumen for advancing connecting members and other instruments through the device to the distal end thereof. Other improved devices include a pacing lead ...
Symptoms of heart failure were assessed using the Kansas City Discussion Our study contributes several key findings to the literature on the outcomes of providing patients access to medical records. At the start of the trial, patients were uniformly positive about the idea of having facilitated ...
The benefits of exercise in the elderly patient with heart failure have been well documented, but the studies have been limited by restrictive inclusion criteria. Most studies have involved patients who are younger and healthier than those normally seen in clinical practice. Improvements in neurohormon...
A patient with congestive heart failure and moderate renal insufficiency developed severe reversible non-oliguric renal failure while on frusemide and enalapril. Renal failure developed when enalapril was given in the presence of pronounced sodium depletion. When positive sodium balance was restored the...
"The randomization of the first patient as a part of the Phase II GenePHIT trial is an important moment for the heart failure community," said Timothy D. Henry, MD, MSCAI, Principal Investigator and Steering Committee Member. "GenePHIT will evaluate the safety and effic...
Antineoplastics: Congestive heart failure (first report with asparaginase), thrombocytopenia and rash in a patient treated with radiotherapy: case reportdoi:10.1127/0028-3649/2004/2004-0525Zn-bearing tetrahedriteZn-Hg bearing tetrahedritecubic unit cell parameterWe report the first measurement of ...